David A. Scheinberg | |
---|---|
Education | Cornell University BA Johns Hopkins University School of Medicine MD, PhD |
Medical career | |
Profession | Physician-scientist |
Institutions | Memorial Sloan Kettering Cancer Center Weill Cornell Medicine |
Sub-specialties | Leukemia |
David A. Scheinberg is an American physician, scientist, drug developer, and entrepreneur, who is Vincent Astor Chair, Chair of the Center for Experimental Therapeutics and former Chair of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK).[1] He is a pioneer and inventor of targeted alpha particle therapies and alpha particle generators for use in patients with cancer.[2][3]